One Sign of Early-Stage Dementia: Hoarding—And How to Cope
When Being Patient founder Deborah Kan’s mother began hoarding blueberry baskets and other miscellaneous items, Kan was taken aback by this new behavior. Kan’s…
When Being Patient founder Deborah Kan’s mother began hoarding blueberry baskets and other miscellaneous items, Kan was taken aback by this new behavior. Kan’s…
A new definition of Alzheimer’s has been published — and it’s drawing a lot of criticism. According to this set of new diagnostic criteria…
Members of the Being Patient community are increasingly curious to learn their genetic status as it relates to Alzheimer’s risk. A story I was…
The genetic risk of developing Alzheimer’s disease is more strongly influenced by the mother’s side than the father’s side, a recent study has discovered….
Some early studies suggested a class of diabetes drugs called GLP-1 agonists, which have been proven to also help people lose weight and reduce…
What will Alzheimer’s treatment look like in five years? At 2024’s Alzheimer’s Association International Conference in Philadelphia, experts provided a sneak peek into the…
According to new diagnostic criteria for Alzheimer’s, a blood test might be all you need to get diagnosed in the near future. At this…
After actor Lauren Miller Rogen’s mother was diagnosed with Alzheimer’s, she and her husband, actor Seth Rogen, decided to apply their powers of entertainment…
In a recent survey, Being Patient put a question to readers: “What is the biggest barrier preventing you from seeking a trial?” The most…
In the past year, the FDA approved two landmark new Alzheimer’s drugs: monoclonal antibodies designed to attack the disease’s underlying pathology, as opposed to…
According to Homer Simpson, alcohol is “the cause of, and solution to, all of life’s problems.” While the patriarch of the Simpson family isn’t…
A new drug for Alzheimer’s was just this month approved by the FDA for use in the United States, in people in the earliest…
UPDATED JULY 3: The Food and Drug Administration has approved Kisunla (generic name donanemab), a new Alzheimer’s drug developed by Eli Lilly. The published data…
Drugmaker Alzheon is currently running clinical trials on a new disease-modifying Alzheimer’s treatment: valiltramiprosate, or ALZ-801. While, like the new buzzy new Alzheimer’s monoclonal…
Here’s the funny thing about Alzheimer’s biomarker blood tests: They can’t actually determine whether or not a person has Alzheimer’s. So what are they…